** India's Nifty pharma index .NIPHARM jumps 4.4% after U.S. President Donald Trump exempted the sector from reciprocal tariffs for now
** Index constituents Dr. Reddy's REDY.NS, Cipla CIPL.NS, Sun Pharma SUN.NS, Gland Pharma GLAD.NS jump 6.1%, 4.1%, 4.1% and 11.7%, respectively
** Trump imposed 26% reciprocal tariffs on Indian imports as part of his wider plan to levy a 10% baseline tariff on all imports from April 5, but the duties do not apply to certain goods, including pharmaceuticals
** U.S. imports nearly a third of Indian pharma products sold overseas
** 19 of the 20 index constituents trading higher on the day, benchmark Nifty 50 .NSEI trading 0.45% lower
(Reporting by Manvi Pant in Bengaluru)
((Manvi.Pant@thomsonreuters.com; +918447554364;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。